Patents Assigned to SensorMedics Corporation
  • Patent number: 9095534
    Abstract: A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.
    Type: Grant
    Filed: February 8, 2012
    Date of Patent: August 4, 2015
    Assignees: SENSORMEDICS CORPORATION, PULMONOX TECHNOLOGIES CORPORATION
    Inventors: Alex Stenzler, Chris Miller, Bevin B. McMullin
  • Patent number: 8795222
    Abstract: Topical exposure of nitric oxide gas to wounds such as chronic non-healing wounds may be beneficial in promoting healing of the wound and in preparing the wound bed for further treatment and recovery. Nitric oxide gas may be used, for example, to reduce the microbial infection and burden on these wounds, manage exudate secretion by reducing inflammation, upregulate expression of endogenous collagenase to locally debride the wound, and regulate the formation of collagen. High concentration of nitric oxide ranging from about 160 to 400 ppm may be used without inducing toxicity in the healthy cells around a wound site. Additionally, exposure to the high concentration for a first treatment period reduces the microbial burden and inflammation at the wound site and increase collagenase expression to debride necrotic tissue at the wound site.
    Type: Grant
    Filed: January 13, 2011
    Date of Patent: August 5, 2014
    Assignees: Pulmonox Technologies Corp., Sensormedics Corporation
    Inventors: Alex Stenzler, Christopher C. Miller
  • Publication number: 20120199123
    Abstract: A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.
    Type: Application
    Filed: February 8, 2012
    Publication date: August 9, 2012
    Applicants: PULMONOX TECHNOLOGIES CORPORATION, SENSORMEDICS CORPORATION
    Inventors: Alex STENZLER, Chris MILLER, Bevin B. MCMULLIN
  • Patent number: 8043252
    Abstract: A method of topically treating the respiratory tract of a mammal with nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas nasally to the upper respiratory tract of the mammal. Also provided are several designs for a nasal delivery device for the controlled nasal deliver the nitric oxide containing gas.
    Type: Grant
    Filed: December 20, 2007
    Date of Patent: October 25, 2011
    Assignees: Sensormedics Corporation, Pulmonox Technologies Corporation
    Inventors: Christopher Miller, Alex Stenzler
  • Publication number: 20110226241
    Abstract: A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.
    Type: Application
    Filed: January 14, 2011
    Publication date: September 22, 2011
    Applicants: SENSORMEDICS CORPORATION, PULMONOX TECHNOLOGIES CORPORATION
    Inventors: Alex STENZLER, Chris Miller, Bevin B. McMullin
  • Patent number: 7955294
    Abstract: A method and corresponding device are described for combating microbes and infections by delivering intermittent high doses of nitric oxide to a mammal for a period of time and which cycles between high and low concentration of nitric oxide gas. The high concentration of nitric oxide is preferably delivered intermittently for brief periods of time that are interspersed with periods of time with either no nitric oxide delivery or lower concentrations of nitric oxide. The method is advantageous because at higher concentration, nitric oxide gas overwhelms the defense mechanism of pathogens that use the mammalian body to replenish their thiol defense system. A lower dose or concentration of nitric oxide gas delivered in between the bursts of high concentration nitric oxide maintains nitrosative stress pressure on the pathogens and also reduces the risk of toxicity of nitric oxide gas.
    Type: Grant
    Filed: November 10, 2006
    Date of Patent: June 7, 2011
    Assignees: Sensormedics Corporation, Pulmonox Technologies Corporation
    Inventors: Alex Stenzler, Christopher C. Miller, Bevin B. McMullin
  • Publication number: 20110112468
    Abstract: Topical exposure of nitric oxide gas to wounds such as chronic non-healing wounds may be beneficial in promoting healing of the wound and in preparing the wound bed for further treatment and recovery. Nitric oxide gas may be used, for example, to reduce the microbial infection and burden on these wounds, manage exudate secretion by reducing inflammation, upregulate expression of endogenous collagenase to locally debride the wound, and regulate the formation of collagen. High concentration of nitric oxide ranging from about 160 to 400 ppm may be used without inducing toxicity in the healthy cells around a wound site. Additionally, exposure to the high concentration for a first treatment period reduces the microbial burden and inflammation at the wound site and increase collagenase expression to debride necrotic tissue at the wound site.
    Type: Application
    Filed: January 13, 2011
    Publication date: May 12, 2011
    Applicants: SENSORMEDICS CORPORATION, PULMONOX TECHNOLOGIES CORPORATION
    Inventors: Alex STENZLER, Christopher C. MILLER
  • Patent number: 7892198
    Abstract: A device for the topical delivery of nitric oxide gas to an infected area of skin includes a source of nitric oxide gas, a bathing unit, a flow control valve, and a vacuum unit. The bathing unit is adapted to surround the area of the infected skin and form a substantially air-tight seal with the skin surface. The bathing unit is also in fluidic communication with the source of nitric oxide. The flow control valve is position downstream of the source of nitric oxide and upstream of the bathing unit. The flow control valve controls the amount of nitric oxide gas that is delivered to the bathing unit. The vacuum unit is positioned downstream of the bathing unit and is used to withdraw gas from the bathing unit. Application of nitric oxide gas to the infected area of skin reduces levels of bacteria in the infected area and promotes the healing process.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: February 22, 2011
    Assignee: Sensormedics Corporation
    Inventor: Alex Stenzler
  • Patent number: 7520866
    Abstract: Topical exposure of nitric oxide gas to wounds such as chronic non-healing wounds may be beneficial in promoting healing of the wound and in preparing the wound bed for further treatment and recovery. Nitric oxide gas may be used, for example, to reduce the microbial infection and burden on these wounds, manage exudate secretion by reducing inflammation, upregulate expression of endogenous collagenase to locally debride the wound, and regulate the formation of collagen. High concentration of nitric oxide ranging from about 160 to 400 ppm may be used without inducing toxicity in the healthy cells around a wound site. Additionally, exposure to the high concentration for a first treatment period reduces the microbial burden and inflammation at the wound site and increase collagenase expression to debride necrotic tissue at the wound site.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: April 21, 2009
    Assignees: Sensormedics Corporation, Pulmonox Technologies Corporation
    Inventors: Alex Stenzler, Chris C Miller
  • Publication number: 20080173311
    Abstract: A method of topically treating the respiratory tract of a mammal with nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas nasally to the upper respiratory tract of the mammal. Also provided are several designs for a nasal delivery device for the controlled nasal deliver the nitric oxide containing gas.
    Type: Application
    Filed: December 20, 2007
    Publication date: July 24, 2008
    Applicants: PULMONOX TECHNOLOGIES CORPORATION, SENSORMEDICS CORPORATION
    Inventors: Christopher Miller, Alex Stenzler
  • Patent number: 7335181
    Abstract: A method of topically treating the respiratory tract of a mammal with nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas nasally to the upper respiratory tract of the mammal. Also provided are several designs for a nasal delivery device for the controlled nasal deliver the nitric oxide containing gas.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: February 26, 2008
    Assignees: Pulmonox Technologies Corporation, Sensormedics Corporation
    Inventors: Christopher Miller, Alex Stenzler
  • Patent number: 7122018
    Abstract: Topical exposure of nitric oxide gas to wounds such as chronic non-healing wounds may be beneficial in promoting healing and preparing the wound bed for further treatment and recovery. Nitric oxide gas may be used to reduce the microbial infection, manage exudates secretion by reducing inflammation, upregulate expression of endogenous collagenase to locally debride the wound, and regulate the formation of collagen. High concentration of nitric oxide ranging from 160–400 ppm may be used without inducing toxicity in the healthy cells around a wound site. Exposure to the high concentration for a first treatment period reduces the microbial burden and inflammation, and increases collagenase expression to debride necrotic tissue at the wound site. After a first treatment period, a second treatment period at a lower concentration of nitric oxide, preferably ranging from 5–20 ppm may be used to restore the balance of nitric oxide and induce collagen expression aiding in the wound closure.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: October 17, 2006
    Assignees: Sensormedics Corporation, Pulmonox Technologies Corporation
    Inventors: Alex Stenzler, Chris C Miller
  • Patent number: 7108666
    Abstract: Disclosed is a method and device for performing forced expiratory maneuver in an infant to assess the infant's pulmonary function. Under this method, the infant's lungs are synchronously inflated to super-atmospheric levels synchronous with the infant's natural tidal inspiration for a plurality of consecutive respiratory cycles. The end-expiratory CO2 levels in the infant's respiration are measured during the test. When the end-expiratory CO2 concentration decreases from the baseline by a pre-defined amount, the infant lungs are rapidly inflated to substantially total lung volume and rapidly deflated to produce a maximum forced expiration. The pre-defined amount of change in CO2 concentration is usually determined by the testing clinician. Typical concentration drop in CO2 levels, for example, ranges between 4 and 8 mmHg. But the decrease may also be as little as 2 mmHg or as much as 15 mmHg, depending on the testing clinician.
    Type: Grant
    Filed: January 7, 2003
    Date of Patent: September 19, 2006
    Assignee: Sensormedics Corporation
    Inventor: Alex Stenzler
  • Patent number: 6840116
    Abstract: A Kelvin sensed hot-wire anemometer includes four electrically conductive pins and a filament welded to all four pins, preferably using a single filament. A current source is coupled to the two innermost pins so as to provide current flow in the segment of filament between the two innermost pins. The two outermost pins are coupled to a high impedance voltage sense amplifier that senses the voltage drop across the energized segment of filament between the two innermost pins. The resistance of the filament is determined based on the current provided to the filament and the measured voltage. The Kelvin sensed hot-wire anemometer can be used in a number of applications, including, but not limited to medical devices that measure gas flow rates during inhalation and exhalation.
    Type: Grant
    Filed: August 29, 2002
    Date of Patent: January 11, 2005
    Assignee: SensorMedics Corporation
    Inventor: John Higgins
  • Patent number: 6793644
    Abstract: A method of treating infected tissue with topical nitric oxide exposure includes the steps of providing a source of nitric oxide containing gas and delivering the nitric oxide containing gas to a skin surface containing infected tissue so as to bathe the infected tissue with nitric oxide.
    Type: Grant
    Filed: June 14, 2002
    Date of Patent: September 21, 2004
    Assignee: Sensormedics Corporation
    Inventor: Alex Stenzler
  • Patent number: 6786217
    Abstract: A device and method is disclosed for delivering NO to a patient. The device utilizes a single controller that controls two separate flow controllers to deliver an oxygen-containing gas and a NO-containing gas to the patient. The flow profiles of the oxygen-containing gas and the NO-containing gas are controlled by the controller. In one aspect of the invention, the flow profile of the NO-containing gas is proportional to the flow profile of the oxygen-containing gas throughout patient inspiration. In this regard, the patient receives a steady concentration of NO. In another aspect of the invention, the flow profile of the NO-containing gas is quasi-proportional to the flow profile of the oxygen-containing gas. In this regard, the NO-containing gas flow profile is altered to provide an increased concentration of NO either at the beginning or end of inspiration.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: September 7, 2004
    Assignee: Sensormedics Corporation
    Inventor: Alex Stenzler
  • Patent number: 6766800
    Abstract: A valve for use in continuous positive airway pressure (CPAP) devices includes a valve body that is disposed at or between the patient mask and the source of positive airway pressure. The valve body includes first and second exhaust paths for exhausting gas from the mask. A floating valve seat is disposed in the valve body and is moveable between first and second positions. A moveable spring-biased piston is releasably engaged with the floating valve seat. When the floating valve seat is in the first position, the moveable spring-biased piston is disengaged from the valve seat and gas travels out the first exhaust flowpath. When the floating valve seat is in the second position, the moveable spring-biased piston is engaged with the valve seat and gas travels out the second exhaust flowpath. The valve provides substantially constant positive airway pressure to the patient at pressures above the threshold pressure level of the valve.
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: July 27, 2004
    Assignee: Sensormedics Corporation
    Inventors: Edmond Chu, Tim Quinn, Larry Murdock, Hung Tran
  • Publication number: 20040129269
    Abstract: Disclosed is a method and device for performing forced expiratory maneuver in an infant to assess the infant's pulmonary function. Under this method, the infant's lungs are synchronously inflated to super-atmospheric levels synchronous with the infant's natural tidal inspiration for a plurality of consecutive respiratory cycles. The end-expiratory CO2 levels in the infant's respiration are measured during the test. When the end-expiratory CO2 concentration decreases from the baseline by a pre-defined amount, the infant lungs are rapidly inflated to substantially total lung volume and rapidly deflated to produce a maximum forced expiration. The pre-defined amount of change in CO2 concentration is usually determined by the testing clinician. Typical concentration drop in CO2 levels, for example, ranges between 4 and 8 mmHg. But the decrease may also be as little as 2 mmHg or as much as 15 mmHg, depending on the testing clinician.
    Type: Application
    Filed: January 7, 2003
    Publication date: July 8, 2004
    Applicant: SENSORMEDICS CORPORATION
    Inventor: Alex Stenzler
  • Publication number: 20040060560
    Abstract: A method and device for effective delivery of a gas such as oxygen for inhalation is provided by sequentially diluting room air to the flow of gas during a respiratory cycle. A mask assembly is described that comprises an inspiratory and expiratory limb each containing a very low resistance one-way valve, and a sequential dilution conduit (leading from the atmosphere to the inspiratory limb) with a one-way valve that has a slightly positive cracking pressure. A gas reservoir is also attached to the inspiratory limb. During expiration, the reservoir is filled with oxygen, for example, flowing from the oxygen source. During inspiration, oxygen from the oxygen source and the reservoir are drawn preferentially. If the oxygen flow is equal to or greater than the minute ventilation of the subject, no atmospheric air is entrained into the mask assembly and the subject gets pure oxygen. If the minute ventilation (tidal volume) exceeds the oxygen flow, the reservoir is depleted.
    Type: Application
    Filed: September 27, 2002
    Publication date: April 1, 2004
    Applicant: SENSORMEDICS CORPORATION
    Inventors: Alex Stenzler, Joseph A. Fisher, Alex Vesely, Hiroshi Sasano, Ron B. Somogyi, George Volgyesi, Steve Iscoe, David Preiss, Eitan Prisman
  • Publication number: 20040040386
    Abstract: A Kelvin sensed hot-wire anemometer includes four electrically conductive pins and a filament welded to all four pins, preferably using a single filament. A current source is coupled to the two innermost pins so as-to provide current flow in the segment of filament between the two innermost pins. The two outermost pins are coupled to a high impedance voltage sense amplifier that senses the voltage drop across the energized segment of filament between the two innermost pins. The resistance of the filament is determined based on the current provided to the filament and the measured voltage. The Kelvin sensed hot-wire anemometer can be used in a number of applications, including, but-not limited to medical devices that measure gas flow rates during inhalation and exhalation.
    Type: Application
    Filed: August 29, 2002
    Publication date: March 4, 2004
    Applicant: SENSORMEDICS CORPORATION
    Inventor: John F. Higgins